Search results for the

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

The Fitness to practise annual report highlights key statistics and insights and explains how we protect the public and ensure our registrants meet our standards

This webinar will explore the benefits regular reflection can have on your practice and share examples of some of the ways you can achieve reflective practice.

Click here to learn what the duty of candour looks like in practice.

In early 2017, the HCPC commenced a review of the Indicative Sanctions Policy to ensure it is up to date, reflects public opinion, and continues to support fair and proportionate decision making. As part of this review we commissioned market research into the public’s views of the Policy and undertook a public consultation.

Brendon Edmonds, Head of Regulatory Development and Performance, breaks down the recent improvements to our international application process

What our standards say on scope of practice

We are seeking views from all our stakeholders on this draft vision, and the other key components which make up our draft corporate strategy

Find out how we'll continue to work with you in the run up to the transfer date

Learn how to overcome the challenges of being open and honest in practice.

Continuing professional development (CPD) should improve your work and have a positive impact for your service users

We required that all education providers embedded our revised standards of proficiency (SOPs) from September 2023. We have assessed education provider alignment with the SOPs, and have considered common practices and challenges with this alignment.